ATE425247T1 - Synthetische peptide und ihre vorbeugende oder therapeutische anwendung für krebsinvasion und metastasen - Google Patents
Synthetische peptide und ihre vorbeugende oder therapeutische anwendung für krebsinvasion und metastasenInfo
- Publication number
- ATE425247T1 ATE425247T1 AT03702506T AT03702506T ATE425247T1 AT E425247 T1 ATE425247 T1 AT E425247T1 AT 03702506 T AT03702506 T AT 03702506T AT 03702506 T AT03702506 T AT 03702506T AT E425247 T1 ATE425247 T1 AT E425247T1
- Authority
- AT
- Austria
- Prior art keywords
- metastasis
- cancer invasion
- therapeutic use
- preventive
- synthetic peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35131702P | 2002-01-23 | 2002-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE425247T1 true ATE425247T1 (de) | 2009-03-15 |
Family
ID=27613485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03702506T ATE425247T1 (de) | 2002-01-23 | 2003-01-23 | Synthetische peptide und ihre vorbeugende oder therapeutische anwendung für krebsinvasion und metastasen |
Country Status (22)
Country | Link |
---|---|
US (1) | US8012935B2 (zh) |
EP (1) | EP1468085B1 (zh) |
JP (1) | JP2005515262A (zh) |
KR (1) | KR20040077764A (zh) |
CN (2) | CN101007844A (zh) |
AT (1) | ATE425247T1 (zh) |
BR (1) | BR0302819A (zh) |
CA (1) | CA2472775A1 (zh) |
DE (1) | DE60326539D1 (zh) |
EE (1) | EE200400030A (zh) |
ES (1) | ES2324027T3 (zh) |
HR (1) | HRP20040732A2 (zh) |
IL (1) | IL162714A0 (zh) |
LV (2) | LV13289B (zh) |
MX (1) | MXPA04007170A (zh) |
NO (1) | NO20034146L (zh) |
NZ (1) | NZ533738A (zh) |
PL (1) | PL209827B1 (zh) |
RU (1) | RU2346043C2 (zh) |
WO (1) | WO2003062413A1 (zh) |
YU (1) | YU76403A (zh) |
ZA (1) | ZA200405328B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2856598B1 (fr) * | 2003-06-25 | 2005-10-28 | Inst Nat Sante Rech Med | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale |
JP4911950B2 (ja) * | 2005-11-07 | 2012-04-04 | 晃 伊東 | Mmp−1の部分ペプチドを用いた癌浸潤・転移阻害薬 |
EP2403508B1 (en) * | 2009-03-06 | 2015-10-28 | Université Paris Descartes | Method of treating cancer employing gingival fibroblast conditioned medium |
US8593732B1 (en) * | 2010-01-23 | 2013-11-26 | Lightsmyth Technologies, Inc. | Partially metallized total internal reflection immersion grating |
US8003110B1 (en) * | 2011-01-24 | 2011-08-23 | Matthias W. Rath | Metalloproteinase oligopeptides and their therapeutic use |
EP2649985A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
GB8817075D0 (en) * | 1988-07-18 | 1988-08-24 | Raychem Ltd | Oscillation suppressor |
US5646027A (en) * | 1994-09-08 | 1997-07-08 | Warner-Lambert Company | Process for the production of gelatinase catalytic domain protein |
CA2864069A1 (en) * | 1999-10-29 | 2001-05-03 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigenic peptides |
-
2003
- 2003-01-23 CA CA002472775A patent/CA2472775A1/en not_active Abandoned
- 2003-01-23 CN CNA2007100054389A patent/CN101007844A/zh active Pending
- 2003-01-23 DE DE60326539T patent/DE60326539D1/de not_active Expired - Lifetime
- 2003-01-23 IL IL16271403A patent/IL162714A0/xx unknown
- 2003-01-23 BR BR0302819-4A patent/BR0302819A/pt not_active IP Right Cessation
- 2003-01-23 NZ NZ533738A patent/NZ533738A/xx unknown
- 2003-01-23 EE EEP200400030A patent/EE200400030A/xx unknown
- 2003-01-23 US US10/350,258 patent/US8012935B2/en not_active Expired - Fee Related
- 2003-01-23 CN CNA038026899A patent/CN1622992A/zh active Pending
- 2003-01-23 PL PL371254A patent/PL209827B1/pl not_active IP Right Cessation
- 2003-01-23 YU YU76403A patent/YU76403A/sh unknown
- 2003-01-23 AT AT03702506T patent/ATE425247T1/de active
- 2003-01-23 MX MXPA04007170A patent/MXPA04007170A/es not_active Application Discontinuation
- 2003-01-23 KR KR10-2004-7011323A patent/KR20040077764A/ko not_active Application Discontinuation
- 2003-01-23 JP JP2003562281A patent/JP2005515262A/ja active Pending
- 2003-01-23 ES ES03702506T patent/ES2324027T3/es not_active Expired - Lifetime
- 2003-01-23 EP EP03702506A patent/EP1468085B1/en not_active Expired - Lifetime
- 2003-01-23 WO PCT/EP2003/000659 patent/WO2003062413A1/en active IP Right Grant
- 2003-01-23 RU RU2004125599/13A patent/RU2346043C2/ru not_active IP Right Cessation
- 2003-09-17 NO NO20034146A patent/NO20034146L/no not_active Application Discontinuation
-
2004
- 2004-07-05 ZA ZA200405328A patent/ZA200405328B/en unknown
- 2004-08-13 HR HR20040732A patent/HRP20040732A2/hr not_active Application Discontinuation
- 2004-09-17 LV LVP-04-102A patent/LV13289B/en unknown
-
2005
- 2005-10-17 LV LVP-05-134A patent/LV13419B/lv unknown
Also Published As
Publication number | Publication date |
---|---|
US20030139345A1 (en) | 2003-07-24 |
EP1468085B1 (en) | 2009-03-11 |
LV13419B (en) | 2006-09-20 |
KR20040077764A (ko) | 2004-09-06 |
CA2472775A1 (en) | 2003-07-31 |
DE60326539D1 (de) | 2009-04-23 |
BR0302819A (pt) | 2004-04-27 |
YU76403A (sh) | 2006-05-25 |
NO20034146D0 (no) | 2003-09-17 |
ES2324027T3 (es) | 2009-07-29 |
PL371254A1 (en) | 2005-06-13 |
IL162714A0 (en) | 2005-11-20 |
JP2005515262A (ja) | 2005-05-26 |
WO2003062413A1 (en) | 2003-07-31 |
MXPA04007170A (es) | 2004-10-29 |
NO20034146L (no) | 2003-10-28 |
US8012935B2 (en) | 2011-09-06 |
CN1622992A (zh) | 2005-06-01 |
EE200400030A (et) | 2004-04-15 |
LV13289B (en) | 2005-11-20 |
CN101007844A (zh) | 2007-08-01 |
RU2004125599A (ru) | 2005-07-10 |
ZA200405328B (en) | 2006-03-29 |
PL209827B1 (pl) | 2011-10-31 |
EP1468085A1 (en) | 2004-10-20 |
HRP20040732A2 (en) | 2005-06-30 |
RU2346043C2 (ru) | 2009-02-10 |
NZ533738A (en) | 2006-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200501976A (en) | Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto | |
MXPA04001033A (es) | Compuesto de sanado para heridas y anti-cancer. | |
DE60213274D1 (de) | Peptide zum einsatz in der behandlung von tumoren und anderen zuständen, die das entfernen oder zerstören von zellen erfordern | |
DK1140969T3 (da) | Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf | |
DE60217507D1 (de) | Peptide für die behandlung von tumoren und anderen zuständen, die das entfernen oder zerstören von zellen erfordern | |
MX2009008270A (es) | Polipeptido novedoso que tiene actividad anti-tumoral. | |
DK1483290T3 (da) | Peptider og peptidmimetika, der har anti-proliferativ aktivitet og/eller forstærker nukleinsyrebeskadigende midler eller behandlinger | |
NO20041700L (no) | Human koagulasjonsfaktor VII-polypeptider | |
HRP20050585A2 (en) | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | |
DE60331546D1 (de) | Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung | |
ATE489462T1 (de) | Antimikrobielles polypeptid und nutzung davon | |
ATE425247T1 (de) | Synthetische peptide und ihre vorbeugende oder therapeutische anwendung für krebsinvasion und metastasen | |
ATE531384T1 (de) | Peptide aus dem plasminogenaktivator-hemmer 1 und ihre verwendung | |
ATE361914T1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
RU2014134287A (ru) | Бифункциональный пептид | |
BR0113147A (pt) | Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos | |
BR0107458A (pt) | Codificação de (poli)peptìdeos que tem atividades chips por meio de ácidos nucleicos | |
LT2004079A (en) | Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis | |
FR2858234B1 (fr) | Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers | |
IL169256A (en) | Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it | |
NO20016341L (no) | Inhibitorer for integrinet <alfa>v<beta>6 | |
ATE544779T1 (de) | Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten | |
WO2002053172A3 (en) | Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover | |
ATE417061T1 (de) | Scorpionpeptid als blutdrucksenkendes mittel | |
DE10293089D2 (de) | Phosphinat-peptidanaloga als Inhibitoren der Procollagen-C-Proteinase (PCP) zur Behandlung von fibrotischen Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1468085 Country of ref document: EP |